Connect with us

Technology

Trenbolone Enanthate Market size is set to grow by USD 13.4 million from 2024-2028, Health benefits of using anabolic steroids boost the market, Technavio

Published

on

NEW YORK, July 15, 2024 /PRNewswire/ — The global trenbolone enanthate market size is estimated to grow by USD 13.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.21%  during the forecast period. Health benefits of using anabolic steroids is driving market growth, with a trend towards emergence of e-commerce platform. However, side effects of trenbolone enanthate  poses a challenge. Key market players include Alpha Pharma Healthcare, Dragon Pharma, Genesis Pharmaceuticals Ltd., Kalpa Pharmaceuticals, Labdhi Pharmaceuticals LLP, and SP Laboratory.

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Trenbolone Enanthate Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 3.21%

Market growth 2024-2028

USD 13.4 million

Market structure

Concentrated

YoY growth 2022-2023 (%)

3.06

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

Europe at 46%

Key countries

US, Germany, China, Canada, and Brazil

Key companies profiled

Alpha Pharma Healthcare, Dragon Pharma, Genesis Pharmaceuticals Ltd., Kalpa Pharmaceuticals, Labdhi Pharmaceuticals LLP, and SP Laboratory

Market Driver

The global trenbolone enanthate market has experienced significant growth with the emergence of e-commerce platforms. Trenbolone enanthate, a popular steroid among bodybuilders and athletes, can now be easily purchased through these online marketplaces. Consumers benefit from a wide range of options, enabling them to compare prices and features before making a purchase. E-commerce platforms like Amazon, eBay, Alibaba, and Rakuten offer consumers the convenience of purchasing from anywhere in the world, making it easier to access hard-to-find products. These platforms contribute positively to the growth of the global trenbolone enanthate market, providing a seamless shopping experience for consumers. 

Trenbolone Enanthate, an anabolic steroid, is a popular choice among bodybuilders and athletes for its ability to build muscle mass, increase strength, and boost metabolic rate. This steroid is particularly effective for those over 30, as it helps combat the natural decline in skeletal muscle and physical performance associated with aging. Trenbolone Enanthate also has psychological benefits, including improved mood and motivation. However, it’s essential to note that Trenbolone Enanthate has reproductive health impacts, including androgenic effects such as body hair growth and acne. Dosages vary, with injections being the most common route of administration, but oral pills and even powder forms are available through various channels, including retail pharmacies, online pharmacies, underground labs, and e-commerce sites. This steroid is also used in veterinary applications for weight gain and performance enhancement in livestock. New drugs and therapies are constantly emerging, but Trenbolone Enanthate remains a sought-after performance-enhancing substance. Be aware that the use of illicit steroids, including Trenbolone Enanthate, can have serious health risks and legal consequences. Always consult a healthcare professional before use. 

Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!

Market Challenges

The trenbolone enanthate market faces significant limitations due to the drug’s potential side effects. Long-term use of this anabolic steroid can lead to dependence, baldness, acne, excessive sweating, increased blood pressure, and suppressed natural testosterone production. Additionally, trenbolone enanthate can negatively impact heart health by reducing HDL cholesterol levels, which is essential for lowering cholesterol. Furthermore, users may experience swelling of ankles, breast enlargement in men, smaller testicles, and prostate stimulation. Women may experience changes in their menstrual cycle, vaginal dryness, and a decrease in breast size with prolonged use. These side effects hinder the expansion of the global trenbolone enanthate market during the forecast period.Trenbolone Enanthate is a popular anabolic androgenic steroid (AAS) used in various applications due to its unique properties. In pharmaceutical industry, it’s used for hormone replacement therapies in conditions like primary and hypogonadotropic hypogonadism, delayed puberty, and metastatic breast cancer. In fitness and bodybuilding, it’s sought after for muscle wasting conditions, hormonal imbalances, and to enhance physical appearance, athletic performance, and strength gains. In gym facilities and fitness activities, bodybuilders use it for lean muscle mass, protein synthesis, nutrient partitioning effects, and mineral absorption. For livestock, it’s used to improve muscle growth and efficiency. However, challenges exist in its use. These include monitoring training frequency and AAS dose, potential side effects like anxiety, insomnia, and aggression, and ethical considerations in sports. Moreover, obesity, chronic wasting diseases, osteoporosis, and testosterone hormone deficiency are growing health concerns. Trenbolone Enanthate can help address some of these issues, but proper medical supervision is crucial due to potential risks and interactions with other medications. Younger generations, fitness bloggers, and athletes are increasingly turning to AAS for quick results, but education about proper use and potential risks is essential. Overall, Trenbolone Enanthate offers significant benefits, but careful consideration and expert guidance are necessary to ensure safe and effective use.

For more insights on driver and challenges – Request a sample report!

Segment Overview 

This trenbolone enanthate market report extensively covers market segmentation by  

Type 1.1 Oral1.2 InjectableApplication 2.1 Bodybuilding2.2 Medical2.3 VeterinaryGeography 3.1 North America3.2 Europe3.3 APAC3.4 South America3.5 Middle East and Africa

1.1 Oral-  Trenbolone Enanthate is a popular anabolic steroid in the bodybuilding community. This steroid is known for its ability to promote muscle growth and increase strength. The market for Trenbolone Enanthate has been growing steadily due to its effectiveness. Suppliers and manufacturers produce this steroid in various forms, including injectable solutions and tablets. Its demand remains high among bodybuilders and athletes seeking to enhance their performance and physique. Despite some potential side effects, the demand for Trenbolone Enanthate continues to increase, making it a significant product in the steroid market.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Learn and explore more about Technavio’s in-depth research reports

The global osteoporosis drugs market is experiencing significant growth due to rising geriatric populations and increased awareness of bone health. Key players are investing in innovative treatments to address the increasing incidence of osteoporosis, driving market expansion.

The global sinus dilation devices market is expanding rapidly, driven by the prevalence of chronic sinusitis and advancements in minimally invasive procedures. Technological innovations in balloon sinuplasty and other dilation techniques are enhancing patient outcomes and boosting market growth, with key players focusing on product development and strategic partnerships.

Research Analysis

Trenbolone Enanthate is a popular anabolic steroid among bodybuilders and athletes for its ability to promote muscle mass, strength gains, and fat loss. This steroid is known for its strong androgenic properties, which can lead to increased vascularity, muscle hardness, and masculinization. However, it also comes with potential side effects such as water retention, anxiety, insomnia, and aggression. Bodybuilders and fitness enthusiasts often use Trenbolone Enanthate in their training regimens to enhance their physical appearance and athletic performance. The steroid can help increase muscle mass, improve strength, and boost metabolic rate, making it an attractive option for those looking to gain an edge in the gym. However, it’s important to note that the use of anabolic androgenic steroids like Trenbolone Enanthate comes with risks. Users may experience side effects such as anxiety, insomnia, and aggression, and long-term use can lead to health issues such as cardiovascular problems and liver damage. To minimize the risks, it’s recommended to use Trenbolone Enanthate under medical supervision and follow a proper training and diet plan. Training frequency, AAS dose, and fitness level are all important factors to consider when using this steroid. Ultimately, the decision to use Trenbolone Enanthate should be based on individual goals, risks, and benefits. In summary, Trenbolone Enanthate is a potent anabolic steroid used by bodybuilders and athletes to enhance muscle mass, strength gains, and fat loss. However, it comes with potential side effects and risks, making it essential to use it responsibly and under medical supervision.

Market Research Overview

Trenbolone Enanthate is a popular anabolic steroid among bodybuilders and athletes for its ability to build muscle mass and improve physical performance. This injectable steroid is known for its effectiveness in promoting lean muscle growth, enhancing vascularity, and increasing muscle hardness. Trenbolone Enanthate works by increasing protein synthesis, nutrient partitioning, and mineral absorption, making it an essential tool for those seeking to maximize their fitness gains. The steroid is available in various forms, including powder and injectable solutions, and can be purchased from various sources such as online pharmacies, underground labs, and e-commerce channels. Trenbolone Enanthate is also used in pharmaceutical applications, including hormone replacement therapies and treatments for muscle wasting conditions and hormonal imbalances. The use of Trenbolone Enanthate extends beyond bodybuilding and athletic circles, with applications in veterinary medicine and livestock farming. However, its use comes with potential side effects, including water retention, anxiety, insomnia, aggression, and reproductive health impacts. Despite its benefits, the use of Trenbolone Enanthate and other anabolic steroids is controversial, with many young people and fitness bloggers turning to them for quick gains. The use of illicit steroids can lead to chronic wasting diseases, obesity, osteoporosis, and other health issues. It is essential to consider the potential risks and consult a healthcare professional before using Trenbolone Enanthate or any other performance-enhancing substance.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

TypeOralInjectableApplicationBodybuildingMedicalVeterinaryGeographyNorth AmericaEuropeAPACSouth AmericaMiddle East And Africa

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/trenbolone-enanthate-market-size-is-set-to-grow-by-usd-13-4-million-from-2024-2028–health-benefits-of-using-anabolic-steroids-boost-the-market-technavio-302196425.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

DATAMARK Technologies Welcomes Industry Veteran Deb Rozeboom to Client Success Team

Published

on

By

Ms. Rozeboom to strengthen client relationships and enhance satisfaction in new role as Client Success Manager

PITTSBURGH, May 19, 2025 /PRNewswire/ — DATAMARK Technologies, a leader in interoperable solutions for public safety location services, today announced that Deb Rozeboom has joined the organization as Client Success Manager. In her new role, Ms. Rozeboom will build lasting relationships with clients, enhance client satisfaction and ensure they derive maximum value from DATAMARK Technologies’ products and services.

Ms. Rozeboom’s efforts will ensure that clients stay at the forefront of public safety geographic information systems (GIS) innovation by consistently delivering services and solutions that align with client objectives and enhance interoperability and effectiveness. This commitment supports the transition to Next Generation 9-1-1 (NG9-1-1) and indoor mapping. At DATAMARK Technologies, Client Success Managers partner with clients to maximize their investments while continually advancing their capabilities.

“DATAMARK Technologies is dedicated to client success and enhancing public safety location services through excellence and advocacy,” said Robert Murphy, Chief Revenue Officer at DATAMARK Technologies. “Deb’s extensive experience in public safety GIS and expertise in NG9-1-1 will be invaluable as we continue to elevate the client experience.”

Ms. Rozeboom joins DATAMARK Technologies with over 20 years of experience managing complex NG9-1-1 projects nationwide. Prior to joining DATAMARK Technologies, she held various roles at GeoComm, including Product Manager, GIS Solutions Engineer and General Manager. Additionally, she has served as an Adjunct Instructor for the National Emergency Numbers Association (NENA), teaching several NG9-1-1 and Addressing courses. She also co-chairs the NENA NG9-1-1 GIS Data Model Standard workgroup and is a member of the Geospatial Professional Network (GPN) Location, Enterprise Addressing and Public Safety (LEAP) Committee.

Ms. Rozeboom holds a Bachelor of Science degree in Ecology and Field Biology, as well as a Master’s Certificate in GIS, from St. Cloud University. She also has several industry certifications, including NENA Emergency Number Professional (ENP), GISC Geographic Information Systems Professional (GISP) and PMI Project Management Professional (PMP).

About DATAMARK Technologies
DATAMARK Technologies provides a new era of 9-1-1 and redefines interoperability for the public safety industry. The company combines DATAMARK, Michael Baker International’s public safety division known for best-in-class geographic information systems (GIS) data management and software solutions, with Digital Data Technologies, LLC (DDT), a top-tier Next Generation 9-1-1 (NG9-1-1) location services provider.

This strategic union heralds a new era of 9-1-1 and redefines geospatial data management for the public safety industry. DATAMARK Technologies offers a fully integrated solution that empowers public safety agencies to manage, maintain and leverage GIS data to the highest industry standards. The unified approach breaks down barriers of data silos to improve call routing accuracy, offer seamless discrepancy resolution and provide unwavering location fidelity for call takers with enhanced interoperability.

Contact: Julia Covelli
julia.covelli@mbakerintl.com 
(866) 293-4609

View original content to download multimedia:https://www.prnewswire.com/news-releases/datamark-technologies-welcomes-industry-veteran-deb-rozeboom-to-client-success-team-302459122.html

SOURCE DATAMARK Technologies

Continue Reading

Technology

Coupa Research Shows CFOs Embrace AI as Antidote to Economic Volatility and Growth Enabler

Published

on

By

Third annual Strategic CFO Study finds 40% of CFOs rank AI as top growth investment area; 90% look to mastering spend management as key to success in tumultuous times

FOSTER CITY, Calif., May 19, 2025 /PRNewswire/ — Amidst global economic uncertainty, rising inflation, and volatile trade, AI investment ranked as the top strategy for growth across all global CFOs surveyed by Coupa – a potential panacea to the volatility they are facing.

The Strategic CFO Report: Turning Global Market Uncertainty into Opportunity, released today by Coupa, the leading AI-native total spend management platform, reveals that almost half (46%) of CFOs see prominent external threats – geopolitics and supply chain disruption – as the greatest risk to business, dampening optimism from the start of 2025. Most notably, the introduction of new tariffs has created an additional challenge for 42% of CFOs, with more than a quarter (28%) of US CFOs planning to or already increasing inventory levels in preparation.

“Today’s finance leaders are facing an alarming set of external pressures and are navigating an ever changing set of risks which challenges their decision making. Despite these dynamic forces, they are driving cost discipline in order to fuel growth, building more resilient supply chains, and scaling their use of AI to fuel more efficient organizations,” said Michael Agresta, Coupa’s CFO. “A unified spend management platform and strategy is proving to be mission-critical in these times to create the agility, visibility, and resilience leaders need to fuel sustainable growth. Coupa’s AI-driven total spend management platform is uniquely built to help our customers navigate uncertainty, and offers CFOs the cloud and AI-native tools to drive margin improvements in any economic environment, making it a critical component for a strategic CFO’s tech stack.”

Tariffs Spur Margin Erosion Concerns
With 69% of CFOs concerned about meeting year-end goals, and 40% reporting extreme concern, it’s clear that much of the financial optimism at the start of the year has dissipated. Most recently, new tariffs and the fear of global trade wars have driven CFOs to act urgently – including increasing inventory levels (22%), automating processes to reduce operating expenses (21%), engaging in hedging strategies (19%), increasing product pricing (19%), and restructuring supply chain (18%). When surveyed on the greatest external threats to business, U.S. CFOs reported slightly lower concern levels (40%) on tariffs compared to their European counterparts, with German CFOs (48%) indicating the highest concern of all countries surveyed.

CFOs Looking to AI to Fuel Growth and Confidence
Despite the uncertain state of the economy, CFOs are asking themselves how best to respond. For today’s finance leaders, this means not over-reacting to every market fluctuation and instead providing thoughtful and inspired leadership – moving away from short-term fixes and prioritizing durable, sustainable growth strategies. A majority (74%) of CFOs are growing increasingly confident in AI, ranking it as the top growth investment area (40% of all CFOs) and AI implementation confidence concerns dropped 23% year-over-year.

“CFOs, including myself, are increasingly championing AI use within their organizations, but to do so effectively they must create a governance structure that is capable of quantifying the performance and financial benefits of AI. Nearly a quarter (23%) of CFOs we surveyed identified this as one of the major obstacles they will face in the next year,” said Agresta. “Beyond the numbers, CFOs need to strategically consider how to prioritize the deployment of new AI strategies and tools across their organizations to identify the highest value use cases but also need to empower employees to think AI first in order to get enterprise-wide adoption.” 

Drowning in Data, Struggling in Silos
In case the state of the economy and trade turmoil wasn’t challenging enough, risk management continues to increase organizational complexity, as 1 in 4 CFOs cited cybersecurity threats, data breaches, and fraud as the largest obstacle they will face this year. CFOs have immense amounts of data at their fingertips – but only 28% of CFOs can access their spend data within a single system and nearly half (41%) struggle to react quickly to cut costs as part of this roadblock. Some organizations are modernizing their data management, but few (33%) have unified processes to manage spend comprehensively. Nearly 1 in 5 CFOs cited outdated systems and data silos as the main hurdles to digital transformation, highlighting the need for increased modern tech adoption to effectively manage data and decrease risk.

Read the full Coupa Clarity Report, The Strategic CFO: Turning Global Market Uncertainty into Opportunity here.

To learn more about Coupa’s leading total spend management platform can help during these turbulent times, visit coupa.com.

Methodology
Coupa Clarity reports provide unique data and insights to help business leaders make smarter decisions to fuel growth, drive efficiency and productivity, and improve performance. This survey was conducted among 500 CFOs and finance leaders across the US, UK, Ireland, France and Germany. The survey was carried out online with an email invitation between November and December 2024 by Wakefield Research on behalf of Coupa.

About Coupa
Coupa is the leader in AI-native total spend management. Using its trusted, community-generated, $8 trillion dataset, Coupa brings autonomous AI agents, a network of 10M+ buyers and suppliers, and leading apps together on one unified platform to seamlessly automate the buying process and connect to customers in a whole new way. With Coupa, you’ll make margins multiply™. Learn more at coupa.com and follow us on LinkedIn and X (Twitter).

View original content to download multimedia:https://www.prnewswire.com/news-releases/coupa-research-shows-cfos-embrace-ai-as-antidote-to-economic-volatility-and-growth-enabler-302458134.html

SOURCE Coupa Software

Continue Reading

Technology

Caltech Announces Eight Recipients of the 2025 National Brown Investigator Award

Published

on

By

Each investigator, recognized for curiosity-driven research in chemistry or physics, will receive up to $2 million over five years.

PASADENA, Calif., May 19, 2025 /PRNewswire/ — The Brown Institute for Basic Sciences at Caltech today announced the 2025 class of Brown Investigators. The cohort, the second to be selected through the Brown Institute for Basic Sciences, comprises eight distinguished mid-career faculty working on fundamental challenges in the physical sciences, particularly those with potential long-term practical applications in chemistry and physics. Each investigator will receive up to $2 million over five years.

The Brown Institute for Basic Sciences at Caltech, established in 2023 through a $400-million gift to the Institute from entrepreneur, philanthropist, and alumnus Ross M. Brown (BS ’56, MS ’57), seeks to advance fundamental science discoveries with the potential to seed breakthroughs that benefit society—a goal it shares with Caltech.

“Mid-career faculty are at a time in their careers when they are poised and prepared to make profound contributions to their fields,” Brown says, “My continuing hope is that the resources provided by the Brown Investigator Awards will allow them to pursue riskier innovative ideas that extend beyond their existing research efforts and align with new or developing passions, especially during this time of funding uncertainty.”

The 2025 investigators are:

Dmitry Abanin, Professor of Physics, Princeton University, to develop a new theoretical and computational framework to describe the emergent properties of quantum materials and synthetic quantum systems away from thermal equilibrium.

László Kürti, Professor of Chemistry, Rice University, to invent chemical strategies for constructing stable neutral polynitrogen cages—molecules made entirely from nitrogen atoms that store extraordinary energy. These elusive structures remain intact under ambient conditions yet release energy on demand without combustion and decompose cleanly into hot nitrogen gas, offering a revolutionary platform for propulsion and energy storage.  

Mark Levin, Associate Professor of Chemistry, University of Chicago, to translate lessons learned from skeletal editing of aromatic compounds (stable chemicals with a flat ring structure) to reactions with aliphatic compounds (three-dimensional, more reactive chemicals), with the goal of providing access to unusual compounds that are inaccessible using traditional chemical synthesis. 

Brad Ramshaw, Associate Professor of Physics, Cornell University, to develop a new technique using ultrasound to probe the electronic states of atomically thin materials.

Cindy Regal, Professor of Physics, University of Colorado Boulder, and Baur-SPIE Chair at JILA, to demonstrate quantum entanglement—a connection between particles like photons or atoms that persists despite their physical distance—with objects of larger mass than have been entangled before.

Xavier Roy, Professor of Chemistry, Columbia University, to design and explore materials in which electrons face competing pathways for motion, giving rise to complex behaviors that, if controlled, could enable new kinds of quantum technologies.

Hailiang Wang, Professor of Chemistry, Yale University, to expand electrocatalysis to convert inorganic waste molecules, such as CO2 and NOx, into valuable and functional organic compounds containing multiple carbon–carbon and carbon–nitrogen bonds.

Joel Yuen-Zhou, Associate Professor of Chemistry and Biochemistry, UC San Diego, for theoretical and computational work to utilize the sensitivity of some chemical reactions to the spin of the electron in photoredox catalysis to make the reaction select one of two enantiomers (mirror-image forms of compounds).

Brown established the Investigator Awards in 2020 through the Brown Science Foundation in support of the belief that “scientific discovery is a driving force in the improvement of the human condition,” according to its news release from the Science Philanthropy Alliance, which helped guide Brown in realizing his philanthropic vision.

“We’re delighted to partner with Ross Brown and the members of the Scientific Advisory Board of the Brown Institute for Basic Sciences to identify and support outstanding investigators in fundamental chemistry and physics,” says Caltech Provost David A. Tirrell, Carl and Shirley Larson Provostial Chair and Ross McCollum-William H. Corcoran Professor of Chemistry and Chemical Engineering.

A total of 21 investigators were recognized in the first four years of the program, including eight in the 2024 class, the first cohort to be installed under the auspices of the Brown Institute for Basic Sciences at Caltech.

Previous awardees include MIT’s Nuh Gedik, who is developing a new kind of microscopy that images electrons photo-emitted from a surface while also measuring their energy and momentum; Kerri A. Pratt from the University of Michigan, for research to discover the chemical compounds and chemical mechanisms that define the composition of the Arctic’s atmosphere, which is warming faster than elsewhere on Earth; Andrea Young of UC Santa Barbara, who is using novel fabrication techniques to make new kinds of qubits, the quantum computing analog of classical bits, in two-dimensional materials; Columbia University’s Tanya Zelevinsky, who studies spectroscopy of cold molecules for fundamental physics; Princeton University’s Waseem Bakr, who works with ultracold quantum gases to realize scalable architectures for quantum computation, and Robert Knowles, whose research will explore a novel hypothesis for the evolution of homochirality—the presence in nature of only one of two mirror-image forms of biomolecules. Caltech’s David Hsieh, Donald A. Glaser Professor of Physics and executive officer for physics, was among two inaugural recipients of the award in 2020.

Brown Investigators from all cohorts are invited to an annual meeting that offers opportunities to share ideas. The second annual meeting was held at Caltech in February 2025.

To determine the new cohort, a select number of research universities from across the country were invited to nominate faculty members who had earned tenure within the last 10 years and who are doing innovative fundamental research in the physical sciences. Nominees were then evaluated by an independent scientific review board that recommended grant winners. In administering the program, Caltech refrains from nominating its own scientists for Brown Investigator Awards. In return, the Institute draws other funds from the Brown gift to support fundamental research in chemistry and physics.

View original content:https://www.prnewswire.com/news-releases/caltech-announces-eight-recipients-of-the-2025-national-brown-investigator-award-302457427.html

SOURCE Caltech

Continue Reading

Trending